$XBIT SEC Filings

Filed On	Filing
26 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers XBiotech Inc. (“Company”) and Jan-Paul Simard (“Executive”) (collectively the “Parties”) hereby enter into this Executive Employment Agreement (the “Agreement”) on this 26th day of October, 2026 (the “Effective Date”). In consideration o...
02 Oct 2026	Proxy statement: annual meeting on November 24, 2026 say-on-pay vote
02 Oct 2026	ARS
13 Aug 2026	FORM 10-Q
14 May 2026	FORM 10-Q
29 Apr 2026	FORM 10-K/A
13 Mar 2026	FORM 10-K
11 Mar 2026	FORM S-8
23 Jan 2026	SCHEDULE 13G/A
23 Jan 2026	SCHEDULE 13G/A
09 Dec 2025	8-K: Departure/Election of Directors or Officers; Compensation
12 Nov 2025	Form 4: Rademaker Craig Evan, Director Granted 92,104 Director Stock Option
12 Nov 2025	Form 4: Soffer David Spencer, Director Granted 51,000 Director Stock Option
12 Nov 2025	Form 4: Kuendig Thomas Martin, Director Granted 79,115 Director Stock Option
12 Nov 2025	Form 4: Troy Tevi David, Director Granted 56,000 Director Stock Option
12 Nov 2025	FORM 10-Q
15 Oct 2025	8-K/A: Departure/Election of Directors or Officers; Compensation XBiotech Inc. (“XBiotech” or the “Company”) files this Form 8-K/A solely to clarify information regarding director Craig Rademaker’s position at the private equity firm referenced in the first sentence of the third paragraph of the June ...
03 Oct 2025	8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation
30 Sep 2025	Form 3: Soffer David Spencer, Director No securities owned
30 Sep 2025	Form 3: Kuendig Thomas Martin, Director Holds 200,000 shares of Common Stock

Comments